Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer

PURPOSE: To assess the immunomodulatory and clinical effects of lenalidomide with standard treatment of gemcitabine in patients with advanced pancreatic cancer. PATIENTS AND METHODS: Patients with advanced pancreatic cancer were treated in first line with lenalidomide orally for 21 days of a 28 days...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullenhag, Gustav J., Mozaffari, Fariba, Broberg, Mats, Mellstedt, Håkan, Liljefors, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242484/
https://www.ncbi.nlm.nih.gov/pubmed/28099502
http://dx.doi.org/10.1371/journal.pone.0169736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242484/
https://www.ncbi.nlm.nih.gov/pubmed/28099502
http://dx.doi.org/10.1371/journal.pone.0169736

Ejemplares similares